Literature DB >> 8157068

Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit.

J Polastron1, J C Meunier, P Jauzac.   

Abstract

Tolerance to chronic morphine treatment was studied in adult rabbits and modifications in the number and the state of coupling of the mu-opioid receptors were investigated in the cerebellum. Tolerance was induced by the subcutaneous injection of progressively increasing doses of morphine (5-100 mg/kg/injection) over 6 days and its occurrence was controlled by a nociceptive test: electrical stimulation of the dental pulp. At the end of the treatment, the rabbits were tolerant to the analgesic effects of morphine and the tolerance phenomenon correlated well with a significant decrease in the adenylate cyclase inhibition (approximately 60%). The functional uncoupling between the enzyme and the mu-opioid receptor was accompanied neither by a decrease in the number of high affinity receptors measured by equilibrium binding techniques (Kd = 0.19 +/- 0.03 in control vs. 0.11 +/- 0.04 nM in tolerant animals; Bmax = 322 +/- 62 vs. 362 +/- 58 fmol/mg of protein), nor by a modification of the physical coupling between the receptor and its G-protein. It can be concluded that desensitization, under our experimental conditions, can be clearly distinguished from down-regulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8157068     DOI: 10.1016/0922-4106(94)90103-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

Authors:  C B Brink; B H Harvey; J Bodenstein; D P Venter; D W Oliver
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

2.  Decreased mu-opioid receptor signalling and a reduction in calcium current density in sensory neurons from chronically morphine-treated mice.

Authors:  Emma E Johnson; Billy Chieng; Ian Napier; Mark Connor
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

3.  The interaction between the mu opioid receptor and filamin A.

Authors:  Eric J Simon; Irma Onoprishvili
Journal:  Neurochem Res       Date:  2010-09-21       Impact factor: 3.996

4.  Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.

Authors:  Dawn C Stoller; Laura J Sim-Selley; Forrest L Smith
Journal:  Brain Res       Date:  2007-01-13       Impact factor: 3.252

5.  Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.

Authors:  Yong Ben; Andrew P Smith; Peter W Schiller; Nancy M Lee
Journal:  Br J Pharmacol       Date:  2004-11-22       Impact factor: 8.739

6.  Chronic morphine treatment up-regulates mu opioid receptor binding in cells lacking filamin A.

Authors:  Irma Onoprishvili; Eric J Simon
Journal:  Brain Res       Date:  2007-08-16       Impact factor: 3.252

Review 7.  Opioid receptor desensitization: mechanisms and its link to tolerance.

Authors:  Stéphane Allouche; Florence Noble; Nicolas Marie
Journal:  Front Pharmacol       Date:  2014-12-18       Impact factor: 5.810

8.  Melatonin regulation of transcription in the reversal of morphine tolerance: Microarray analysis of differential gene expression.

Authors:  Yu-Che Cheng; Ru-Yin Tsai; Yen-Tseng Sung; Ing-Jung Chen; Tzu-Yi Tu; Ya-Yuan Mao; Chih-Shung Wong
Journal:  Int J Mol Med       Date:  2018-12-18       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.